These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15339683)

  • 21. [Levels of plasma TF and TFPI activities in patients with acute leukemia].
    Zhu Y; Xie ZX; He XF; Han JZ; Li JC; He SL
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):401-2, 405. PubMed ID: 12206017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue factor pathway inhibitor (TFPI) levels in the plasma and urine of children with meningococcal disease.
    Eling M; Stephens AC; Oragui EE; Rivers RP; Levin M
    Thromb Haemost; 2001 Feb; 85(2):240-4. PubMed ID: 11246540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease.
    Opstad TB; Pettersen AA; Bratseth V; Arnesen H; Seljeflot I
    Pathophysiol Haemost Thromb; 2010; 37(2-4):98-103. PubMed ID: 21555871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
    Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of tissue factor in patients undergoing open repair of ruptured and nonruptured abdominal aortic aneurysms.
    Hobbs SD; Haggart P; Fegan C; Bradbury AW; Adam DJ
    J Vasc Surg; 2007 Oct; 46(4):682-6. PubMed ID: 17764874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
    Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII.
    Peverill RE; Teede HJ; Smolich JJ; Malan E; Kotsopoulos D; Tipping PG; McGrath BP
    Clin Sci (Lond); 2001 Jul; 101(1):93-9. PubMed ID: 11410120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome.
    Atsumi T; Khamashta MA; Andujar C; Leandro MJ; Amengual O; Ames PR; Hughes GR
    J Rheumatol; 1998 Jan; 25(1):69-73. PubMed ID: 9458205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
    Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
    Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway.
    López-Pedrera C; Buendía P; Cuadrado MJ; Siendones E; Aguirre MA; Barbarroja N; Montiel-Duarte C; Torres A; Khamashta M; Velasco F
    Arthritis Rheum; 2006 Jan; 54(1):301-11. PubMed ID: 16385547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity.
    Salemink I; Franssen J; Willems GM; Hemker HC; Li A; Wun TC; Lindhout T
    Thromb Haemost; 1998 Aug; 80(2):273-80. PubMed ID: 9716152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High titers of autoantibodies to tissue factor pathway inhibitor are associated with the antiphospholipid syndrome.
    Forastiero RR; Martinuzzo ME; Broze GJ
    J Thromb Haemost; 2003 Apr; 1(4):718-24. PubMed ID: 12871406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of protease-activated receptors in monocytes from patients with primary antiphospholipid syndrome.
    López-Pedrera C; Aguirre MA; Buendía P; Barbarroja N; Ruiz-Limón P; Collantes-Estevez E; Velasco F; Khamashta M; Cuadrado MJ
    Arthritis Rheum; 2010 Mar; 62(3):869-77. PubMed ID: 20131237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased plasma tissue factor pathway inhibitor activity in ischemic stroke patients.
    Abumiya T; Yamaguchi T; Terasaki T; Kokawa T; Kario K; Kato H
    Thromb Haemost; 1995 Oct; 74(4):1050-4. PubMed ID: 8560412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early heparin administration attenuates tissue factor-mediated thrombin generation during simulated cardiopulmonary bypass.
    Morizumi S; Hiramatsu Y; Matsuzaki K; Goto Y; Sato S; Abe M; Kato H; Matsubara M; Sakakibara Y
    J Card Surg; 2014 Jan; 29(1):35-40. PubMed ID: 24266905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
    Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein S is a cofactor for tissue factor pathway inhibitor.
    Rosing J; Maurissen LF; Tchaikovski SN; Tans G; Hackeng TM
    Thromb Res; 2008; 122 Suppl 1():S60-3. PubMed ID: 18691502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and biology of tissue factor pathway inhibitor.
    Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
    Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombin generation in vitro and in vivo, and disturbed tissue factor regulation in patients with acute pancreatitis.
    Lindström OK; Tukiainen EM; Kylänpää ML; Mentula PJ; Puolakkainen PA; Wartiovaara-Kautto UM; Repo H; Petäjä JM
    Pancreatology; 2011; 11(6):557-66. PubMed ID: 22213026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of autoantibody-induced monocyte tissue factor expression.
    Wolberg AS; Roubey RA
    Thromb Res; 2004; 114(5-6):391-6. PubMed ID: 15507269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.